FDA Inspection
Quest Diagnostics Inc. at Lovelace Medical CenterQuest Diagnostics Inc. at Lovelace Medical Center – FDA Inspection, May 20, 2014
Record Details
This FDA Inspection record concerns Quest Diagnostics Inc. at Lovelace Medical Center, with an inspection on May 20, 2014, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- May 20, 2014
- Product Type
- Biologics
View Company Profile
ID · c1811cb1-a20a-4c50-b685-398ef233b150
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 879392
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
3- 21 CFR 606.121(f)Labeling of blood products unsuitable for transfusion
- 21 CFR 606.100(b)(13)Procedures to relate blood from donor to final disposition
- 21 CFR 606.100(b)Establish, maintain and follow manufacturing SOPs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Quest Diagnostics Inc. at Lovelace Medical Center
1| Date | Classification | Office | Project area |
|---|---|---|---|
| January 23, 2009 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Quest Diagnostics Inc. at Lovelace Medical Center
- FDA Inspection 564153 - 2009-01-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.